Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Atypical antipsychotics and effects on feeding: from mice to men
Louise Benarroch, Chantel Kowalchuk, Virginia Wilson, et al.
Psychopharmacology (2016) Vol. 233, Iss. 14, pp. 2629-2653
Closed Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia
Nicole E. MacKenzie, Chantel Kowalchuk, Sri Mahavir Agarwal, et al.
Frontiers in Psychiatry (2018) Vol. 9
Open Access | Times Cited: 160
Antipsychotic Drugs: From Receptor-binding Profiles to Metabolic Side Effects
Spyridon Siafis, Dimitrios Tzachanis, Myrto Samara, et al.
Current Neuropharmacology (2017) Vol. 16, Iss. 8, pp. 1210-1223
Open Access | Times Cited: 128
The Complex Relationship between Antipsychotic-Induced Weight Gain and Therapeutic Benefits: A Systematic Review and Implications for Treatment
Alex Raben, Victoria S. Marshe, Araba Chintoh, et al.
Frontiers in Neuroscience (2018) Vol. 11
Open Access | Times Cited: 101
Antipsychotic-Induced Weight Gain in Severe Mental Illness: Risk Factors and Special Considerations
Nicolette Stogios, Bailey Humber, Sri Mahavir Agarwal, et al.
Current Psychiatry Reports (2023) Vol. 25, Iss. 11, pp. 707-721
Closed Access | Times Cited: 32
The microbiome-gut-brain axis: implications for schizophrenia and antipsychotic induced weight gain
Sarah Kanji, Trehani M. Fonseka, Victoria S. Marshe, et al.
European Archives of Psychiatry and Clinical Neuroscience (2017) Vol. 268, Iss. 1, pp. 3-15
Closed Access | Times Cited: 73
Understanding the Effects of Antipsychotics on Appetite Control
Sayani Mukherjee, Silje Skrede, Edward Milbank, et al.
Frontiers in Nutrition (2022) Vol. 8
Open Access | Times Cited: 34
Roles of inflammation in intrinsic pathophysiology and antipsychotic drug-induced metabolic disturbances of schizophrenia
Tyler R. Prestwood, Roshanak Asgariroozbehani, Sally Wu, et al.
Behavioural Brain Research (2021) Vol. 402, pp. 113101-113101
Open Access | Times Cited: 37
A phenotypic Caenorhabditis elegans screen identifies a selective suppressor of antipsychotic-induced hyperphagia
Anabel Pérez‐Gómez, Maria Carretero, Natalie Weber, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 32
Exploring Patterns of Disturbed Eating in Psychosis: A Scoping Review
Nicolette Stogios, Emily R. Smith, Roshanak Asgariroozbehani, et al.
Nutrients (2020) Vol. 12, Iss. 12, pp. 3883-3883
Open Access | Times Cited: 29
Olanzapine, but not haloperidol, exerts pronounced acute metabolic effects in the methylazoxymethanol rat model
Kateřina Horská, Silje Skrede, Jan Kučera, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 2
Open Access | Times Cited: 3
Who is at risk for weight gain after weight‐gain associated treatment with antipsychotics, antidepressants, and mood stabilizers: A machine learning approach
Julia Eder, Catherine Glocker, Barbara B. Barton, et al.
Acta Psychiatrica Scandinavica (2024) Vol. 151, Iss. 3, pp. 231-244
Open Access | Times Cited: 3
Brain insulin action: Implications for the treatment of schizophrenia
Sri Mahavir Agarwal, Chantel Kowalchuk, L Castellani, et al.
Neuropharmacology (2019) Vol. 168, pp. 107655-107655
Closed Access | Times Cited: 28
Olanzapine-induced endoplasmic reticulum stress and inflammation in the hypothalamus were inhibited by an ER stress inhibitor 4-phenylbutyrate
Meng Xiao He, Xu‐Feng Huang, Guanbin Gao, et al.
Psychoneuroendocrinology (2019) Vol. 104, pp. 286-299
Closed Access | Times Cited: 26
Blood-Based Lipidomics Approach to Evaluate Biomarkers Associated With Response to Olanzapine, Risperidone, and Quetiapine Treatment in Schizophrenia Patients
Adriano Aquino, Guilherme L. Alexandrino, Paul C. Guest, et al.
Frontiers in Psychiatry (2018) Vol. 9
Open Access | Times Cited: 26
A robust and miniaturized screening platform to study natural products affecting metabolism and survival in Caenorhabditis elegans
Julia Zwirchmayr, Benjamin Kirchweger, Theresa Lehner, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 23
Binge Eating Disorders in Antipsychotic-Treated Patients With Schizophrenia
Renaud de Beaurepaire
Journal of Clinical Psychopharmacology (2021) Vol. 41, Iss. 2, pp. 114-120
Closed Access | Times Cited: 19
Atypical antipsychotics: recent research findings and applications to clinical practice: Proceedings of a symposium presented at the 29th Annual European College of Neuropsychopharmacology Congress, 19 September 2016, Vienna, Austria
Robin M. Murray, Christoph U. Correll, Gavin P. Reynolds, et al.
Therapeutic Advances in Psychopharmacology (2017) Vol. 7, Iss. 1_suppl, pp. 1-14
Open Access | Times Cited: 22
Do proinflammatory cytokines play a role in clozapine-associated glycometabolism disorders?
Tongtong Zhao, Kai Zhang, Yelei Zhang, et al.
Psychopharmacology (2021) Vol. 238, Iss. 7, pp. 1979-1990
Open Access | Times Cited: 17
Relationships between food-related behaviors, obesity, and medication use in individuals with Smith-Magenis syndrome
Anusha Gandhi, Theresa A. Wilson, Stephanie Sisley, et al.
Research in Developmental Disabilities (2022) Vol. 127, pp. 104257-104257
Closed Access | Times Cited: 12
The Association Between Antipsychotics and Weight Gain and the Potential Role of Metformin Concomitant Use: A Retrospective Cohort Study
Alqassem Y. Hakami, Razaz Felemban, Rami Ghazi Ahmad, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 12
One-Year Treatment with Olanzapine Depot in Female Rats: Metabolic Effects
Kari M. Ersland, Lene Secher Myrmel, Even Fjære, et al.
The International Journal of Neuropsychopharmacology (2019) Vol. 22, Iss. 5, pp. 358-369
Open Access | Times Cited: 18
Lipoic acid and haloperidol-induced vacuous chewing movements: Implications for prophylactic antioxidant use in tardive dyskinesia
Joshua G. Lister, Ana C. Andreazza, Bushra Navaid, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2016) Vol. 72, pp. 23-29
Closed Access | Times Cited: 13
Clozapine reduces nicotine self‐administration, blunts reinstatement of nicotine‐seeking but increases responding for food
Andrew R. Abela, Zhaoxia Li, Anh D. Lê, et al.
Addiction Biology (2018) Vol. 24, Iss. 4, pp. 565-576
Closed Access | Times Cited: 14
Clozapine reliably increases the motivation for food: parsing the role of the 5-HT2c and H1 receptors
Andrew R. Abela, Xiao Dong Ji, Zhaoxia Li, et al.
Psychopharmacology (2020) Vol. 237, Iss. 4, pp. 957-966
Closed Access | Times Cited: 12
Clozapine suppresses NADPH oxidase activation, counteracts cytosolic H2O2, and triggers early onset mitochondrial dysfunction during adipogenesis of human liposarcoma SW872 cells
Giulia Blandino, Mara Fiorani, Barbara Canonico, et al.
Redox Biology (2023) Vol. 67, pp. 102915-102915
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top